Friday, May 22, 2026

Hair Relaxer and Paraquat Claims Drive Daily Federal Mass Tort Filings

Federal dockets registered 58 new mass tort filings on May 21, 2026, driven predominantly by a sustained wave of product liability and legacy toxic tort claims. The undeniable anchor of the day's activity was the Hair Relaxer Litigation (MDL 3060), which recorded 15 new complaints. Plaintiffs in this sprawling docket allege that major cosmetics manufacturers concealed how endocrine-disrupting chemicals in their products significantly increase the risk of uterine, ovarian, and endometrial cancers.

Momentum also gathered in the Paraquat Litigation (MDL 3004) with seven new filings, spearheaded by Hochman Law Firm PLLC (6) and supported by a single suit from The Smith Law Firm PLLC (1). Agricultural workers in this docket consistently allege that prolonged exposure to the controversial herbicide directly causes Parkinson's disease. Simultaneously, the Johnson & Johnson Talc Litigation (MDL 2738) added six new cases claiming that asbestos-tainted talcum powder causes ovarian cancer. This activity drew contributions from a diversified plaintiffs' bar including Ashcraft Gerel LLP (2), Golomb Legal APC (1), Moore Law Group (1), The Smith Law Firm PLLC (1), and Weitz & Luxenberg PC (1).

Consumer product and platform-based liability dockets maintained matching velocity, each logging six new complaints. The Philips CPAP Litigation (MDL 3014) saw a concentrated push exclusively from Dicello Levitt LLP (6) over allegations that degrading sound-abatement foam causes severe respiratory issues and cancer. On the tech front, the Uber Sexual Assault Litigation (MDL 3084) brought in six new suits asserting the ride-hailing platform failed to protect passengers from predatory drivers, featuring filings from Cutter Law PC (2), Nachawati Law Group PLLC (2), Nigh Goldenberg Raso Vaughn PLLC (1), and The Carlson Law Firm PC (1). As discovery phases mature across both legacy and newly consolidated dockets, practitioners should watch for emerging pharmaceutical mass torts to potentially eclipse traditional product liability volumes in the coming quarters.

JPML Sets May 28 Hearing for Spinal Cord Stimulator Consolidation

Plaintiffs pursuing product liability claims over allegedly defective spinal implants are approaching a critical procedural milestone, with the Judicial Panel on Multidistrict Litigation scheduled to hear arguments for centralization on May 28, 2026. The impending hearing will determine whether to consolidate the growing volume of lawsuits against major device manufacturers into a single proceeding designated as proposed MDL 3181. Plaintiffs allege that the companies' spinal cord stimulators are prone to severe malfunctions, such as lead migration or unintended electrical shocks, that can cause permanent nerve damage and paralysis. If the panel grants the motion at the May 28 session, the resulting centralization will streamline discovery and pretrial proceedings for a device category that has faced escalating medical scrutiny.

Former FCI Dublin Guard Sentenced to 52 Months as Abuse Scandal Concludes Criminal Phase

On May 1, 2026, a federal judge sentenced former correctional officer Jeffrey Wilson to 52 months in prison for sexually abusing an incarcerated woman at the now-shuttered FCI Dublin facility in California. Wilson is the tenth and final former employee to face sentencing in connection with the systemic sexual abuse scandal that ultimately forced the Bureau of Prisons to close the women's prison in 2024. While the criminal prosecutions of the facility's staff have now concluded, the underlying institutional failures continue to drive massive civil liability exposure for the federal government. The closure of the prison and the successful criminal convictions provide crucial evidentiary anchors for the civil rights lawsuits filed by survivors seeking compensation for the permissive culture of abuse.